Srilatha Edupuganti Selected Research

Srilatha Edupuganti Research Topics

Disease

20	Infections 11/2023 - 01/2011
16	COVID-19 07/2023 - 01/2020
14	Human Influenza (Influenza) 01/2021 - 01/2011
4	Viremia 12/2023 - 12/2012
4	Virus Diseases (Viral Diseases) 11/2020 - 05/2008
4	Influenza in Birds (Avian Flu) 12/2014 - 09/2014
3	Yellow Fever 01/2013 - 05/2008
2	Neoplasms (Cancer) 07/2023 - 01/2022
2	Vaccinia 01/2023 - 09/2015
2	Lung Neoplasms (Lung Cancer) 11/2022 - 01/2022
2	Breakthrough Infections 01/2022 - 10/2021
2	Dengue (Dengue Fever) 01/2019 - 12/2016
2	Zika Virus Infection 01/2019 - 12/2016
1	Tuberculosis (Tuberculoses) 11/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022
1	Venezuelan Equine Encephalomyelitis 01/2022
1	Equine Encephalomyelitis (Equine Encephalitis) 01/2022
1	Neutropenia 01/2022
1	Rubella (German Measles) 01/2019
1	Mumps 01/2019
1	Measles 01/2019
1	Tularemia 01/2017
1	Headache (Headaches) 01/2017
1	Vesicular Stomatitis 09/2015
1	Hepatitis A (Hepatitis, Infectious) 01/2013
1	Hepatitis B 12/2012
1	Epidural Abscess 06/2011
1	Osteomyelitis 06/2011
1	Typhoid Fever (Typhoid) 01/2009
1	Smallpox (Variola) 05/2008

Drug/Important Bio-Agent (IBA)

30	VaccinesIBA 11/2023 - 05/2008
16	AntibodiesIBA 11/2023 - 01/2011
14	Neutralizing AntibodiesIBA 07/2023 - 01/2011
8	Immunoglobulin G (IgG)IBA 11/2022 - 01/2019
6	Monoclonal AntibodiesIBA 12/2023 - 01/2011
6	Proteins (Proteins, Gene)FDA Link 07/2023 - 01/2020
6	Immunoglobulin M (IgM)IBA 10/2021 - 12/2012
5	Broadly Neutralizing AntibodiesIBA 01/2023 - 01/2011
5	AntigensIBA 01/2022 - 03/2011
4	2019-nCoV Vaccine mRNA-1273IBA 07/2023 - 02/2021
3	EpitopesIBA 11/2023 - 01/2011
3	Ad26COVS1IBA 07/2023 - 10/2021
3	BNT162 VaccineIBA 07/2023 - 10/2021
3	Adenosine Monophosphate (AMP)IBA 01/2023 - 01/2017
3	MF59 oil emulsionIBA 12/2014 - 10/2014
2	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2015
2	AIDS VaccinesIBA 07/2023 - 01/2017
2	DNA VaccinesIBA 01/2023 - 01/2015
2	mRNA VaccinesIBA 11/2022 - 01/2022
2	AerosolsIBA 11/2022 - 01/2017
2	COVID-19 VaccinesIBA 01/2022 - 10/2021
2	Immunoglobulin A (IgA)IBA 12/2020 - 05/2020
2	Viral RNAIBA 11/2020 - 01/2018
2	CytokinesIBA 01/2020 - 01/2013
2	Immunoglobulins (Immunoglobulin)IBA 04/2013 - 01/2013
2	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 04/2013 - 12/2009
1	Messenger RNA (mRNA)IBA 07/2023
1	NVX-CoV2373 adjuvated lipid nanoparticleIBA 07/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 03/2022
1	Complement System Proteins (Complement)IBA 03/2022
1	2-(2,4-dimethylphenyl)indan-1,3-dioneIBA 03/2022
1	Biological Warfare AgentsIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	aluminum sulfate (alum)IBA 01/2022
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2021
1	NucleoproteinsIBA 01/2021
1	Combined VaccinesIBA 10/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	HLA-DR Antigens (HLA-DR)IBA 01/2020
1	InterferonsIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2019
1	EnzymesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	IgG Receptors (Fc gamma RI)IBA 12/2016
1	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 09/2015
1	Phosphates (Orthophosphate)IBA 01/2015
1	Inactivated VaccinesIBA 01/2015
1	Influenza Vaccines (Influenza Vaccine)FDA Link 09/2014
1	GlucocorticoidsIBA 06/2011
1	Subunit VaccinesIBA 03/2011
1	Hemagglutinins (Hemagglutinin)IBA 01/2011
1	Indicators and Reagents (Reagents)IBA 12/2009

Therapy/Procedure

3	Therapeutics 01/2022 - 07/2021
1	Intravenous Infusions 01/2017
1	Highly Active Antiretroviral Therapy (HAART) 12/2012